A new era in phosphate binder therapy: What are the options?

Slides:

Advertisements

Similar presentations

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Advertisements

Pleiotropic effects of the non-calcium phosphate binder sevelamer

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Tumoral calcinosis in a peritoneal dialysis patient

Beta blockers in the management of chronic kidney disease

Volume 69, Issue 5, Pages (March 2006)

Anemia management in chronic kidney disease

Microalbuminuria, peripheral artery disease, and cognitive function

Impact of new dialysis solutions on peritonitis rates

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,

Progression of renal failure and hypertensive nephrosclerosis

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Francesco Paolo Schena Kidney International

Volume 68, Issue 4, Pages (October 2005)

Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real? S. Andrulli, S. Di Filippo, F. Locatelli

Volume 71, Issue 8, Pages (April 2007)

Volume 70, Pages S21-S25 (December 2006)

Volume 66, Pages S13-S17 (September 2004)

Volume 62, Issue 1, Pages (July 2002)

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Pleiotropic effects of the non-calcium phosphate binder sevelamer

Volume 70, Issue 11, Pages (December 2006)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 66, Pages S25-S32 (September 2004)

Volume 87, Issue 2, Pages (February 2015)

Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.

Volume 71, Issue 11, Pages (June 2007)

Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease S. Bianchi, R. Bigazzi, V.M. Campese

Volume 73, Pages S5-S17 (April 2008)

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

Volume 71, Issue 6, Pages (March 2007)

Volume 69, Issue 3, Pages (February 2006)

Volume 70, Issue 12, Pages (December 2006)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Blood pressure targets in hemodialysis patients

Volume 69, Issue 10, Pages (May 2006)

Fructose intake as a risk factor for kidney stone disease

Role of vitamin D receptor activators on cardiovascular risk

Recent experience with high-dose intravenous iron administration

The third World Kidney Day: Looking back and thinking forward

Volume 72, Issue 1, Pages 8-10 (July 2007)

Tumoral calcinosis in a peritoneal dialysis patient

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Microbiology and outcomes of peritonitis in North America

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.

Volume 73, Pages S72-S75 (April 2008)

Volume 71, Issue 4, Pages (February 2007)

Fibroblast growth factor 23: the making of a hormone

Phosphate binders on iron basis: A new perspective?

Organ transplantation goes to the movies

Volume 70, Pages S84-S90 (November 2006)

Volume 55, Pages S3-S16 (June 1999)

Is it the low-protein diet or simply the salt restriction?

Charles A. Herzog Kidney International

Urinalysis in Western culture: A brief history

Volume 70, Issue 3, Pages (August 2006)

Volume 70, Issue 9, Pages (November 2006)

Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate S. Aime, C. Canavese, P. Stratta Kidney International

Volume 70, Issue 5, Pages (September 2006)

Mild renal insufficiency is associated with reduced coronary flow in patients with non- obstructive coronary artery disease A.R. Chade, D. Brosh, S.T.

Volume 72, Issue 11, Pages (December 2007)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 69, Issue 8, Pages (April 2006)

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Volume 72, Issue 12, (December 2007)

Change in coronary artery calcification in patients who were treated with calcium or sevelamer. Change in coronary artery calcification in patients who.

Presentation transcript:

A new era in phosphate binder therapy: What are the options? I.B. Salusky Kidney International Volume 70, Pages S10-S15 (December 2006) DOI: 10.1038/sj.ki.5001997 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Absolute change from baseline calcification scores in patients treated with sevelamer or a calcium-based phosphate binder: results from the TTG study.32 Kidney International 2006 70, S10-S15DOI: (10.1038/sj.ki.5001997) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Percentage increase in coronary artery calcification scores during treatment with sevelamer or a calcium-based phosphate binder in patients with a baseline coronary artery calcification score>30.33 Kidney International 2006 70, S10-S15DOI: (10.1038/sj.ki.5001997) Copyright © 2006 International Society of Nephrology Terms and Conditions